Incontinence is a leading side effect of
prostate cancer treatment, and Depend® will donate per
purchase of select Depend® products up to $350,000 to support prostate cancer
research
NEENAH,
Wis., Sept. 1, 2022 /PRNewswire/ -- The
Depend® brand is igniting conversations about the importance
of men proactively taking charge of their health and championing
the strength of those fighting prostate cancer with its third year
of the Stand Strong for Men's Health™ initiative, benefiting the
Prostate Cancer Foundation (PCF). Beginning in September, Prostate
Cancer Awareness Month, Depend® will donate up to
$350,0001 toward PCF's
work to improve the early detection and treatment of prostate
cancer.
In the United States, one in
eight men are diagnosed with prostate cancer in their lifetime, and
many survivors experience urinary incontinence as a side effect of
treatment.2 With a new case diagnosed every three
minutes, preventative checks are critical for men's health.
Screening starts with a simple blood test to detect the level of
prostate-specific antigen (PSA), a protein produced by the
prostate, with very small amounts released into the bloodstream can
help catch the disease at an early stage when treatment may be more
effective.3
"PCF is grateful for the Depend® brand's Stand Strong
for Men's Health™ initiative, which helps fund life-saving research
that contributes to detecting and treating prostate cancer," said
Dr. Charles Ryan, President and CEO
of The Prostate Cancer Foundation. "Deciding to screen and
ultimately treat prostate cancer is a highly personal decision.
Education and research are vital in determining the best path
forward for both the doctor and patient."
For father, actor and Depend® partner Brian Austin Green, the Stand Strong for Men's
Health™ message is personal. Green lives with ulcerative colitis,
which some studies have linked to a possible increased risk for
prostate cancer.4
"After my ulcerative colitis diagnosis, I recognized my risk for
prostate cancer and made a commitment to my personal health, not
only for my family but also for other men in my shoes," said
Brian Austin Green. "While learning
more about the Depend® Stand Strong for Men's Health™
program and speaking with my doctor, I've decided to complete a PSA
test to ensure I continue to prioritize my preventative care."
For men diagnosed with prostate cancer, research funded by
PCF has led to breakthroughs in evaluation and treatment, such as
the prostate-specific membrane antigen (PSMA)-PET scan. This
technology allows doctors to see and track otherwise hard-to-find
prostate cancer, potentially earlier and in much smaller amounts
compared with imaging that is currently used. PSMA-based technology
can also be used as a treatment for certain types of advanced
prostate cancer to precisely deliver tiny doses of radiation to
prostate cancer cells.
"Depend® brand's Stand Strong for Men's Health is
designed to help fight the stigmas associated with these health
issues and celebrate the courage and strength of men taking charge
of their health," said Adam Dreyer,
Senior Brand Manager of the Depend® brand. "We have
donated annually through Stand Strong for Men's Health™ to PCF to
fund prostate cancer research, and this fall the brand is providing
an easy way for people to make an impact."
For every purchase of Depend® Shields-Underwear Liners for Men –
Light and Depend® Real Fit Underwear for Men September through
November, Depend® will donate to PCF, up to $350,000.5 More details about the
Stand Strong for Men's Health™ initiative can be found at
Depend.com/Stand-Strong. For more on the Prostate Cancer Foundation
and how Depend® is accelerating its research mission,
please visit: pcf.org/depend.
About the Depend® Brand
Launched in 1984 by Kimberly-Clark Corporation, the
Depend® brand is the market leader in the adult
incontinence category in North America. Over the years, the
Depend® brand has evolved with its consumers to provide
the exceptional protection and lend them the confidence they need
to lead normal, active lives. For more information or to request a
product sample, visit www.Depend.com.
About Kimberly-Clark
Kimberly-Clark (NYSE: KMB) and
its trusted brands are an indispensable part of life for people in
more than 175 countries. Fueled by ingenuity, creativity, and an
understanding of people's most essential needs, we create products
that help individuals experience more of what's important to them.
Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex,
Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus,
Neve, Plenitud, Sweety, Softex, Viva and WypAll, hold the No. 1 or
No. 2 share position in 80 countries. We use sustainable practices
that support a healthy planet, build stronger communities, and
ensure our business thrives for decades to come. To keep up with
the latest news and to learn more about the company's 150-year
history of innovation, visit Kimberly-Clark.com.
About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world's leading
philanthropic organization dedicated to funding life-saving
prostate cancer research. Founded in 1993 by Mike Milken, PCF has
been responsible for raising close to one
billion dollars in support of cutting-edge research by more
than 2,200 research projects at 245 leading cancer centers in 28
countries around the world. Since PCF's inception, and through its
efforts, patients around the world are living longer, suffering
fewer complications, and enjoying better quality of life. PCF is
committed to creating a global public square for prostate cancer,
in service to our mission of ending death and suffering from the
disease. Learn more at www.pcf.org.
[KMB-B]
1 Depend® will donate $0.50 to Prostate Cancer Foundation for each
Depend® Shields and Depend® Real-Fit product
purchased in the United States
9/1/2022 – 11/30/2022. Maximum
Donation $350,000. NOTE: PCF is not
registered in Mississippi, so the
promotion will be VOID in MS. Visit pcf.org for more
information.
2 According to the Prostate Cancer Foundation
3 According to the Prostate Cancer Foundation
4 Association between inflammatory bowel disease and
prostate cancer: A large-scale, prospective, population-based
study. [published May 13, 2020].
Cancer Epidemiology.
5 Depend® will donate $0.50 to Prostate Cancer Foundation for each
Depend® Shields and Depend® Real-Fit product
purchased in the United States
9/1/2022 – 11/30/2022. Maximum
Donation $350,000. NOTE: PCF is not
registered in Mississippi, so the
promotion will be VOID in MS. Visit pcf.org for more
information.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/depend-brand-champions-third-annual-stand-strong-for-mens-health-initiative-with-brian-austin-green-to-benefit-the-prostate-cancer-foundation-301616353.html
SOURCE Kimberly-Clark